Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy – Business Wire (press release)
CNBC |
Celgene Corporation to Acquire Juno Therapeutics, Inc., Advancing Global Leadership in Cellular Immunotherapy
Business Wire (press release) SUMMIT, N.J. & SEATTLE–(BUSINESS WIRE)–Celgene Corporation (NASDAQ:CELG) and Juno Therapeutics, Inc. (NASDAQ:JUNO) today announced the signing of a definitive merger agreement in which Celgene has agreed to acquire Juno. Under the terms of the merger … Celgene To Buy Juno Therapeutics In $9 Bln Deal; Reaffirms 2020 Targets Celgene snaps up Juno in $9bn deal Juno Therapeutics (JUNO) Rating Lowered to Sell at Zacks Investment Research |
